Loading...
XMADPRM
Market cap175mUSD
Dec 20, Last price  
9.86EUR
1D
-0.80%
1Q
-7.42%
Jan 2017
10.79%
Name

Prim SA

Chart & Performance

D1W1MN
XMAD:PRM chart
P/E
13.24
P/S
0.77
EPS
0.74
Div Yield, %
3.72%
Shrs. gr., 5y
-0.37%
Rev. gr., 5y
10.00%
Revenues
217m
+9.77%
64,494,03371,953,99190,542,33291,630,05295,760,93795,496,61895,111,84091,446,38488,662,28387,000,32794,205,58299,227,781110,099,596121,272,878134,429,946150,998,844147,323,948168,512,431197,245,073216,510,625
Net income
13m
+51.02%
4,744,2515,710,8347,554,94710,060,2179,903,88910,034,9228,531,9608,908,8609,135,1439,634,2689,961,52710,702,84713,096,66213,897,88114,118,96311,218,1256,917,30117,422,5908,391,26812,672,570
CFO
-31m
L
0000000000012,245,80611,596,29512,438,4136,574,479652,23725,958,90526,304,7934,889,666-31,245,065
Dividend
Jul 17, 20240.2269 EUR/sh

Profile

Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
URL
https://www.prim.es/
IPO date
Jan 21, 1997
Employees
827
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
216,511
9.77%
197,245
17.05%
168,512
14.38%
Cost of revenue
136,911
128,850
104,612
Unusual Expense (Income)
NOPBT
79,600
68,395
63,900
NOPBT Margin
36.76%
34.68%
37.92%
Operating Taxes
4,353
2,482
5,636
Tax Rate
5.47%
3.63%
8.82%
NOPAT
75,247
65,913
58,264
Net income
12,673
51.02%
8,391
-51.84%
17,423
151.87%
Dividends
(6,239)
(8,839)
(5,401)
Dividend yield
3.51%
4.80%
2.16%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
16,964
10,279
7,993
Long-term debt
15,226
18,576
16,727
Deferred revenue
2
550
200
Other long-term liabilities
1,295
2,924
574
Net debt
12,640
10,738
(18,188)
Cash flow
Cash from operating activities
(31,245)
4,890
26,305
CAPEX
(10,390)
Cash from investing activities
(4,204)
Cash from financing activities
30,369
FCF
63,156
48,934
46,724
Balance
Cash
13,248
14,941
36,538
Long term investments
6,301
3,176
6,370
Excess cash
8,724
8,255
34,483
Stockholders' equity
128,450
128,069
140,807
Invested Capital
143,819
136,399
106,066
ROIC
53.71%
54.37%
57.90%
ROCE
51.37%
46.86%
45.26%
EV
Common stock shares outstanding
17,010
17,060
17,220
Price
10.45
-3.24%
10.80
-25.77%
14.55
50.00%
Market cap
177,757
-3.52%
184,244
-26.47%
250,554
49.12%
EV
193,268
194,981
232,366
EBITDA
89,643
76,772
70,799
EV/EBITDA
2.16
2.54
3.28
Interest
826
281
135
Interest/NOPBT
1.04%
0.41%
0.21%